TRCT
ONCO icon

Tower Research Capital (TRC)’s Onconetix ONCO Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164 Hold
145
– – ﹤0.01% 5107
2026
Q1 		$2.17K Buy
145
+109
+303% +$5.68K ﹤0.01% 4530
2025
Q4 		$2.84K Buy
36
+5
+16% +$688 ﹤0.01% 4467
2025
Q3 		$4.88K Buy
31
+24
+343% +$4.04K ﹤0.01% 4287
2025
Q2 		$1.57K Buy
7
+5
+250% +$1.47K ﹤0.01% 4787
2025
Q1 		$580 Hold
2
– – ﹤0.01% 4866
2024
Q4 		$4.21K Buy
+2
New +$20.2K ﹤0.01% 4494
2024
Q3 		– Hold
0
– – – 5543
2024
Q2 		– Hold
0
– – – 5048
2024
Q1 		– Hold
0
– – – 5288
2023
Q4 		– Hold
0
– – – 5346
2023
Q3 		– Hold
0
– – – 4915
2023
Q2 		– Hold
0
– – – 4506
2023
Q1 		– Hold
0
– – – 5223
2022
Q4 		– Hold
0
– – – 3853
2022
Q3 		– Hold
0
– – – 5817

Other funds holding ONCO

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s ONCO Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Onconetix (ONCO) position steady in Q2 2026 at 145 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #5107.

Tower Research Capital (TRC) first reported a position in ONCO in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.88K in Q3 2025. 6 funds tracked by Wall St. Rank hold ONCO as of Q2 2026.

  • Tower Research Capital (TRC) held 145 shares of Onconetix worth $164 as of Q2 2026.
  • Tower Research Capital (TRC) left its Onconetix share count unchanged in Q2 2026.
  • Onconetix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5107 holding.
  • Tower Research Capital (TRC) first reported a position in Onconetix in Q4 2024 and has held it in 7 quarters since.
  • Tower Research Capital (TRC)'s Onconetix position peaked at $4.88K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Onconetix as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.